It is not approved by the FDA for any medical purpose, and that single fact shapes how every honest vendor lists it
The longest data available is 68 weeks (Phase 3) and 48 weeks (Phase 2)
Houshmand-Oeregaard A, Hansen NS, Hjort L, Kelstrup L, Broholm C, Mathiesen ER, et al
Ma T, Lu W, Wang Y, Qian P, Tian H, Gao X, et al
Compare Tirzepatide with Other GLP-1 Medications: Cost and Effectiveness In the landscape of GLP-1 medications, this drug stands out due to its impressive weight loss results, often achieving an average reduction of up to 20% over 72 weeks
Interference of a prostaglandin E2-analogue, enprostil